Prelude Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Buy |
16,152
+6,000
| +59% | +$45.2K | 0.01% | 877 |
|
|
2025
Q1 | $76.9K | Buy |
+10,152
| New | +$76.9K | 0.01% | 975 |
|
|
2024
Q1 | – | Sell |
-17,844
| Closed | -$182K | – | 1225 |
|
|
2023
Q4 | $182K | Buy |
17,844
+5,300
| +42% | +$54K | 0.01% | 833 |
|
|
2023
Q3 | $114K | Buy |
+12,544
| New | +$114K | 0.01% | 835 |
|
|
2023
Q2 | – | Sell |
-11,044
| Closed | -$113K | – | 1039 |
|
|
2023
Q1 | $113K | Sell |
11,044
-500
| -4% | -$5.12K | 0.01% | 844 |
|
|
2022
Q4 | $122K | Buy |
+11,544
| New | +$122K | 0.01% | 905 |
|